Diagnostics Partnering Focus Areas

We strive to identify biomarkers that address significant unmet medical needs to enable novel and important physician decision making along the entire continuum of a patient’s journey. We are interested in clinically validated biomarkers in a variety of indications including:

• Cardiovascular diseases, Infectious diseases, Central nervous system diseases, including brain traumatism, Women's health, Respiratory diseases, Coagulation and haematology, Autoimmune diseases and inflammation, Diabetes and other metabolic diseases, Oncology

We are committed to diagnostic innovation and have pioneered the integration of clinical chemistry and immunochemistry. The key now is to expand the core lab, consolidating and integrating further a wider range of platforms.

Our areas of focus include:

• Novel technologies for handling and storage of samples prior to analysis of proteins and metabolites

• Fractionation and depletion technologies 

• New platforms e.g. multiplexing and reagents for improved metabolite or protein analysis 

• Scalable automation solutions

• Pioneering new fields/ applications for protein and metabolomics markers

We want to bring lab-quality to point of care and patient self testing to enable making the best treatment decisions possible when patients need it most. Our areas of focus include:

• Platforms and technologies supporting hospital care, ambulatory care and patient self testing (e.g. immunochemistry, clinical chemistry, blood gas & electrolytes, complete blood count, infectious disease, nucleic acid testing)

• Pioneering new fields/applications for Point-of-Care and near patient testing (e.g. breath analysis, wearable sensors, physiological testing)

• New platforms and technologies with fully automated sample handling and detection functionality, lab like performance, and lowest cost disposables

• IT solutions supporting Integrated diagnostic information anywhere, anytime (e.g. smart apps, communicating sensors with smartphones, disposable read out with smartphones)

The vision of Roche Diabetes Care is to help people with diabetes everywhere in the world think less about their daily diabetes routine so they can get true relief, day and night. Our areas of focus include forming collaborations on:

• Solutions that accelerate and enhance our portfolio of glucose monitoring technologies and insulin delivery systems

• Services and solutions that enable digital diabetes management

• If you have a promising technology, why not get in touch with us?

A new generation of tests supports healthcare providers in choosing medications based on molecular characteristics of diseases and in monitoring treatments. Our areas of focus include:

• Novel technologies for handling and storage of samples prior to nucleic acid testing

• Isolation, enrichment and amplification technologies for nucleic acid testing

• New platforms and reagents for improved nucleic acid testing

• New technologies to measure nucleic acid modifications (i.e. epigenomics)

• Pioneering new fields/ applications for Next Generation Sequencing

We are constantly looking for new ways to standardise and optimise processes in pathology, haematology or other specialty labs. Our areas of focus include:

• Novel technologies for handling and storage of tissue and blood samples prior to analysis

• Rare cell enrichment technologies

• New platforms for automated pre-analytics for tissue and cell analytics

• New platforms and reagents for improved immunohistochemistry, complete blood count, and cytology

• Solutions to support digitalisation of pathology lab

Our goal is to support clinicians and other relevant stakeholders for the benefit of patients by providing the right decision support at the right time and through comprehensive digital offerings. Our Focus Areas for Innovation:

• Automation and integration of different in vitro testing disciplines (Serology, Immunology, Molecular, Tissue...)

• Physical connectivity for the transport of samples without human intervention

• Virtual connectivity to ensure proper orchestration of testing operations

• Business Analytics for critical insights into the laboratory value chain

• Smart algorithms (ML,AI) for data aggregation, analysis and transformation

• Clinical decision making

Our purpose within Diagnostics and Roche Group is to build a sustainable insights business for labs, providers and patients. The DIA Partnering RIS Network will focus efforts on providing digital solutions for existing and new customers. High interest technologies include:

Healthcare data interoperability and integration

Healthcare data activation

Tools to extract, create, and curate longitudinal patient records

Clinical workflow engines

Patient engagement and disease management

Home and remote care technologies

Digital tools with a focus on oncology and neurology

Our goal is to have a greater impact on patients and society by offering comprehensive customer solutions, increasing patient access and driving better healthcare outcomes. We are interested in:

• Anatomic Pathology

• Companion Diagnostics

• Digital Pathology

• Digital Diagnostics

• Tissue Research